Synthesis, In vitro Antibacterial and Antimycobacterial Activity and Docking Study of Thieno(3,2-e)(1,2,4)triazolo(1,5-c)pyrimidines

Author:

Akkinepally Raghuram Rao1,Malothu Narender2,Jojula Malathi3,Kaki Venkat Rao4,Adidala Raghuram Reddy3

Affiliation:

1. Department of Pharmaceutical Chemistry, University College of Pharmaceutical Sciences, Kakatiya University, Vidyaranyapuri, Warangal 506009, India

2. Department of Pharmaceutical Chemistry, KL College of Pharmacy, Koneru Lakshamaiah Education Foundation, Vaddeswaram, AP, India

3. Department of Microbiology, Sri Shivani College of Pharmacy, Warangal 506004, India

4. Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, India

Abstract

Background: Emergence of drug resistance and severe side effects with current an-titubercular drugs urges the development of more efficacious and safer new agents. The present study focused on this direction to develop new hetero-fused pyrimidines as potential antitubercu-lar agents. Objective: The objective of the study was to synthesize and assess the antibacterial and antimy-cobacterial activity of novel 1,2,4-triazole ring bearing hetero-fused thienopyrimidines (6a-j & 7a-j). Also to evaluate the binding pattern of synthesized molecules at the target site and study their ADME properties by in silico tools. Methods: Two series of hetero fused thienopyrimidines (6a-j & 7a-j) were synthesized and tested for their antibacterial potentiality against B. subtilis, S. aureus, E. coli, and K. pneumonia. Com-pounds with potential antibacterial activity were further tested for their antitubercular activity against Mycobacterium tuberculosis (MTB) H37Rv and an isoniazid (INH)-resistant clinical sam-ple of MTB using broth microdilution method. The binding efficacy at the enzyme site was eval-uated by the molecular docking study using pantothenate synthetase (MTB-PS) (PDB: 3IVX) as the target protein. Further, in silico ADME properties of title compounds were explored by Swiss ADME online tools. Results: In this study, few compounds were found promising in exhibiting potent inhibitory ac-tivity against E. coli and MTB. Among these compounds, 6h (MTB: MIC-17.13±0.88 μM) and 6i (MTB: MIC-17.55±0.72 μM) displayed significant antimycobacterial activity. The molecular docking results suggested the efficient binding of biologically potential molecules. Conclusion: Compounds bearing N-benzyl moiety at the core nucleus with a p-nitro aryl side chain (6h) exhibited significant antitubercular activity. In silico studies showed effective binding at the target site and also indicated good compatibility in ADME properties.

Publisher

Bentham Science Publishers Ltd.

Subject

Infectious Diseases,Pharmacology

Reference19 articles.

1. WHO Global tuberculosis report. Available from:2019

2. Gualano G.; Capone S.; Matteelli A.; Palmieri F.; New antituberculosis drugs: From clinical trial to programmatic use. Infect Dis Rep 2016,8(2),6569

3. Szumowski J.D.; Lynch J.B.; Profile of delamanid for the treatment of multidrug-resistant tuberculosis. Drug Des Devel Ther 2015,9,677-682

4. Shetty N.S.; Lamani R.S.; Khazi I.A.; Synthesis and antimicrobial activity of some novel thienopyrimidines and triazolothieno-pyrimidines. J Chem Sci 2009,121(3),301-307

5. Shetty N.S.; Gaonkar S.L.; Pai V.V.; Manvith S.K.; Synthesis and antimicrobial activity of tricyclic thienopyrimidines and 1, 3, 4-Triazole fused thienopyrimidines. J Chem Sci Tech 2011,2(1),10-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3